BACKGROUND AND PURPOSE: Reported associations between risk of radiation-induced normal tissue injury and single nucleotide polymorphisms (SNPs) in TGFB1, encoding the pro-fibrotic cytokine transforming growth factor-beta 1 (TGF-β1), remain controversial. To overcome publication bias, the international Radiogenomics Consortium collected and analysed individual patient level data from both published and unpublished studies. MATERIALS AND METHODS: TGFB1 SNP rs1800469 c.-1347T>C (previously known as C-509T) genotype, treatment-related data, and clinically-assessed fibrosis (measured at least 2years after therapy) were available in 2782 participants from 11 cohorts. All received adjuvant breast radiotherapy. Associations between late fibrosis or overall toxicity, reported by STAT (Standardised Total Average Toxicity) score, and rs1800469 genotype were assessed. RESULTS: No statistically significant associations between either fibrosis or overall toxicity and rs1800469 genotype were observed with univariate or multivariate regression analysis. The multivariate odds ratio (OR), obtained from meta-analysis, for an increase in late fibrosis grade with each additional rare allele of rs1800469 was 0.98 (95% Confidence Interval (CI) 0.85-1.11). This CI is sufficiently narrow to rule out any clinically relevant effect on toxicity risk in carriers vs. non-carriers with a high probability. CONCLUSION: This meta-analysis has not confirmed previous reports of association between fibrosis or overall toxicity and rs1800469 genotype in breast cancer patients. It has demonstrated successful collaboration within the Radiogenomics Consortium.
BACKGROUND AND PURPOSE: Reported associations between risk of radiation-induced normal tissue injury and single nucleotide polymorphisms (SNPs) in TGFB1, encoding the pro-fibrotic cytokine transforming growth factor-beta 1 (TGF-β1), remain controversial. To overcome publication bias, the international Radiogenomics Consortium collected and analysed individual patient level data from both published and unpublished studies. MATERIALS AND METHODS:TGFB1 SNP rs1800469 c.-1347T>C (previously known as C-509T) genotype, treatment-related data, and clinically-assessed fibrosis (measured at least 2years after therapy) were available in 2782 participants from 11 cohorts. All received adjuvant breast radiotherapy. Associations between late fibrosis or overall toxicity, reported by STAT (Standardised Total Average Toxicity) score, and rs1800469 genotype were assessed. RESULTS: No statistically significant associations between either fibrosis or overall toxicity and rs1800469 genotype were observed with univariate or multivariate regression analysis. The multivariate odds ratio (OR), obtained from meta-analysis, for an increase in late fibrosis grade with each additional rare allele of rs1800469 was 0.98 (95% Confidence Interval (CI) 0.85-1.11). This CI is sufficiently narrow to rule out any clinically relevant effect on toxicity risk in carriers vs. non-carriers with a high probability. CONCLUSION: This meta-analysis has not confirmed previous reports of association between fibrosis or overall toxicity and rs1800469 genotype in breast cancerpatients. It has demonstrated successful collaboration within the Radiogenomics Consortium.
Authors: Susan Martin; Mark Sydenham; Joanne Haviland; Roger A'Hern; Roger Owen; Judith Bliss; John Yarnold Journal: Radiother Oncol Date: 2010-10 Impact factor: 6.280
Authors: Catharine West; Barry S Rosenstein; Jan Alsner; David Azria; Gillian Barnett; Adrian Begg; Søren Bentzen; Neil Burnet; Jenny Chang-Claude; Eric Chuang; Charlotte Coles; Kim De Ruyck; Dirk De Ruysscher; Alison Dunning; Rebecca Elliott; Laura Fachal; Janet Hall; Karin Haustermans; Carsten Herskind; Tobias Hoelscher; Takashi Imai; Mayumi Iwakawa; Don Jones; Cecilia Kulich; Jan-Hans Langendijk; Peter O'Neils; Mahmut Ozsahin; Matthew Parliament; Andrzej Polanski; Barry Rosenstein; Daniela Seminara; Paul Symonds; Chris Talbot; Hubert Thierens; Ana Vega; Catherine West; John Yarnold Journal: Int J Radiat Oncol Biol Phys Date: 2010-04 Impact factor: 7.038
Authors: Alice Y Ho; Grace Fan; David P Atencio; Sheryl Green; Silvia C Formenti; Bruce G Haffty; Preetha Iyengar; Jonine L Bernstein; Richard G Stock; Jamie A Cesaretti; Barry S Rosenstein Journal: Int J Radiat Oncol Biol Phys Date: 2007-05-22 Impact factor: 7.038
Authors: Gillian C Barnett; Catharine M L West; Charlotte E Coles; Paul D P Pharoah; Christopher J Talbot; Rebecca M Elliott; George A Tanteles; R Paul Symonds; Jennifer S Wilkinson; Alison M Dunning; Neil G Burnet; Søren M Bentzen Journal: Int J Radiat Oncol Biol Phys Date: 2011-05-24 Impact factor: 7.038
Authors: Gillian C Barnett; Charlotte E Coles; Rebecca M Elliott; Caroline Baynes; Craig Luccarini; Don Conroy; Jennifer S Wilkinson; Jonathan Tyrer; Vivek Misra; Radka Platte; Sarah L Gulliford; Matthew R Sydes; Emma Hall; Søren M Bentzen; David P Dearnaley; Neil G Burnet; Paul D P Pharoah; Alison M Dunning; Catharine M L West Journal: Lancet Oncol Date: 2011-12-12 Impact factor: 41.316
Authors: C J Talbot; G A Tanteles; G C Barnett; N G Burnet; J Chang-Claude; C E Coles; S Davidson; A M Dunning; J Mills; R J S Murray; O Popanda; P Seibold; C M L West; J R Yarnold; R P Symonds Journal: Br J Cancer Date: 2012-07-05 Impact factor: 7.640
Authors: Deborah E Citrin; Pataje G S Prasanna; Amanda J Walker; Michael L Freeman; Iris Eke; Mary Helen Barcellos-Hoff; Molykutty J Arankalayil; Eric P Cohen; Ruth C Wilkins; Mansoor M Ahmed; Mitchell S Anscher; Benjamin Movsas; Jeffrey C Buchsbaum; Marc S Mendonca; Thomas A Wynn; C Norman Coleman Journal: Radiat Res Date: 2017-05-10 Impact factor: 2.841
Authors: Christian Nicolaj Andreassen; Barry S Rosenstein; Sarah L Kerns; Harry Ostrer; Dirk De Ruysscher; Jamie A Cesaretti; Gillian C Barnett; Alison M Dunning; Leila Dorling; Catharine M L West; Neil G Burnet; Rebecca Elliott; Charlotte Coles; Emma Hall; Laura Fachal; Ana Vega; Antonio Gómez-Caamaño; Christopher J Talbot; R Paul Symonds; Kim De Ruyck; Hubert Thierens; Piet Ost; Jenny Chang-Claude; Petra Seibold; Odilia Popanda; Marie Overgaard; David Dearnaley; Matthew R Sydes; David Azria; Christine Anne Koch; Matthew Parliament; Michael Blackshaw; Michael Sia; Maria J Fuentes-Raspall; Teresa Ramon Y Cajal; Agustin Barnadas; Danny Vesprini; Sara Gutiérrez-Enríquez; Meritxell Mollà; Orland Díez; John R Yarnold; Jens Overgaard; Søren M Bentzen; Jan Alsner Journal: Radiother Oncol Date: 2016-07-18 Impact factor: 6.280
Authors: Carsten Herskind; Christopher J Talbot; Sarah L Kerns; Marlon R Veldwijk; Barry S Rosenstein; Catharine M L West Journal: Cancer Lett Date: 2016-03-02 Impact factor: 8.679
Authors: Asim Alam; Nitai D Mukhopadhyay; Yi Ning; Leonid B Reshko; Robert J G Cardnell; Omair Alam; Christopher S Rabender; Vasily A Yakovlev; Linda Walker; Mitchell S Anscher; Ross B Mikkelsen Journal: Int J Radiat Oncol Biol Phys Date: 2015-06-06 Impact factor: 7.038
Authors: H Li; G Liu; L Xia; Q Zhou; J Xiong; J Xian; M Du; L Zhang; L Liao; X Su; Z Li; Q Luo; Y Cheng; T Zhang; D Wang; Z-Z Yang Journal: Br J Radiol Date: 2014-06-02 Impact factor: 3.039
Authors: Dustin L Boothe; Shana Coplowitz; Eleni Greenwood; Christian L Barney; Paul J Christos; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; A Gabriella Wernicke Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-16 Impact factor: 7.038